Twenty Years and Over a Thousand Citations, But It Couldn’t Be Reproduced

[From the commentary “Novelty in science should not come at the cost of reproducibility” by Andrew Holding, published in The FEBS Journal] “Oestrogen receptor (ER) cycling is a dogma of the Oestrogen receptor-positive (ER+) breast cancer field.” “For nearly 20…

Read More

Novelty Versus Prediction

[From the article, “Point of View: How should novelty be valued in science?” by Barak A. Cohen, published in the journal eLife] “Scientists are under increasing pressure to do “novel” research. Here I explore whether there are risks to overemphasizing…

Read More